bioRxivCell Biology
Breast cancer dormancy is associated with a 4NG1 state and not senescence
C. Prunier, A. Alay, M. van Dijk, K. L. Ammerlaan, S. van Gelderen, D. L. Marvin, A. Teunisse, R. C. Slieker, K. Szuhai, A. G. Jochemsen, X. Sole, P. ten Dijke, L. Ritsma
Abstract
Reactivation of dormant cancer cells can lead to cancer relapse, metastasis and patient death. Dormancy is a non-proliferative state and is linked to late relapse and death. No targeted therapy is currently available to eliminate dormant cells, highlighting the need for a deeper understanding and reliable models. Here, we thoroughly characterize the dormant D2.OR and proliferative D2A1 breast cancer cell line models in vivo and in vitro, and assess if there is overlap between a dormant and a senescent phenotype. We show that D2.OR but not D2A1 cells become dormant in the liver of an immunocompetent model. In vitro, we show that D2.OR cells are polyploid ER+/Her2+ cells, and in response to a 3D environment are growth arrested in G1, of which a subpopulation resides in a 4NG1 state. The dormancy state is reversible, and not associated with a senescence phenotype. This will aid future research on breast cancer dormancy.
- organism: mouse
- assay: bulk RNA-seq
- research focus: cell type annotation
- research focus: cell signaling & trafficking
- research focus: cancer & tumor microenvironment
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Natural killer cell regulation of breast cancer stem cells mediates metastatic dormancy.
G. G. Bushnell, D. Sharma, … M. S. Wicha·bioRxiv·Oct 2, 2023
- Live Cell Lineage Tracing of Dormant Cancer Cells
H. Kim, A. Wirasaputra, … S. Peyton·bioRxiv·Oct 8, 2022
- Inducible re-epithelialization of cancer cells increases autophagy and DNA damage: implications for breast cancer dormancy
Diana Drago Garcia, Suvendu Giri, … Yosef Yarden·bioRxiv·Feb 9, 2025
- Epithelial-mesenchymal plasticity determines estrogen receptor positive (ER+) breast cancer dormancy and reacquisition of an epithelial state drives awakening
A. Patrik, Z. Yueyun, … C. Brisken·bioRxiv·Jul 22, 2021
- The CXCL10/CXCR3 axis is essential for sustaining immunological dormancy in breast cancer
Alev Yilmaz, Lisa Haerri, … Curzio Rüegg·bioRxiv·Sep 26, 2025
- Tumor cell-organized fibronectin is required to maintain a dormant breast cancer population